Drugs / KCl
last change Nov 2021 re-read 2 minutes ago

KCl

Developed for
COVID-19
Investigated by
Amr kamel khalil Ahmed · Kafrelsheikh University

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT05003492 Sep → Oct 2021 COVID-19 Amr kamel khalil Ahmed Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as KCl “Patients will receive an Enriched Grape Juice containing 234.5 mmol microcrystalline KCl (a total of 6000 mg of K in 2 EGJ, but split into 2 intakes daily)” NCT05003492